A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis

PHASE3CompletedINTERVENTIONAL
Enrollment

286

Participants

Timeline

Start Date

March 10, 2021

Primary Completion Date

July 31, 2022

Study Completion Date

February 1, 2023

Conditions
Dermatitis, AtopicDermatitisEczemaSkin DiseasesSkin Diseases, Genetic
Interventions
DRUG

Lebrikizumab

Administered SC

DRUG

Placebo

Administered SC

DRUG

Topical Corticosteroid

Self-applied

Trial Locations (37)

9330871

Shirasaki Clinic, Takaoka-shi

272-0143

Yanagihara dermatology clinic, Ainokawa, Ichikawa-shi

272-0033

Kawashima Dermatology Clinic, Ichikawa-shi

270-2223

Charme Clinique, Matsudo

818-0083

Yasumoto Dermatology Clinic, Chikushino-shi

811-3217

Hino Dermatology Clinic, Fukutsu

734-8551

Hiroshima University Hospital, Hiroshima

080-0013

Takagi Dermatology, Obihiro

060-0063

Sapporo Skin Clinic, Sapporo

060-0807

Kobayashi Skin Clinic, Sapporo

657-0846

Dermatology Shimizu Clinic, Kobe

300-0395

Ibaraki Medical Center, Inashiki-gun

921-8801

KAJI Dermatology Clinic, Nonoichi-shi

211-0063

Kosugi Dermatology Clinic, Kawasaki

220-6208

Queen's Square Dermatology and Allergology, Nishi-ku, Yokohama-city

221-0825

Nomura Dermatology Clinic, Yokohama

861-3101

Noguchi Dermatology, Kashima-machi, Kamimashiki-gun

860-0066

Jyouzanhihuka・Hinyoukika Clinic, Kumamoto

583-8588

Osaka Habikino Medical Center, Habikino

595-0025

Mochida Dermatology Clinic, Izumiotsu-shi

593-8324

Kume Clinic, Sakai

569-0824

Yoshikawa Dermatology Clinic, Takatsuki

330-0854

Sanrui Dermatology Clinic, Ohmiya-ku,Saitama-shi

321 0293

Dokkyo Medical University Hospital, Shimotsuga-Gun

101-0021

Akihabara Skin Clinic, Chiyoda-ku

133-0057

Sumire Dermatology Clinic, Edogawa-ku

136-0074

Maruyama Dermatology Clinic, Koto-ku

194-0013

Hamaguchi Skin Clinic, Machida-shi

108-0014

Mita Dermatology Clinic, Minato-Ku

143-0023

Tanpopo Dermatology Clinic, Ōta-ku

169-0075

Yamate Dermatological Clinic, Shinjuku

130-0014

Yoshihara Dermatology Clinic, Sumida-ku

190-0023

Tachikawa Dermatology Clinic, Tachikawa-shi

819-0167

Matsuda Tomoko Dermatological Clinic, Fukuoka

602 8566

Kyoto Furitsu Medical University Hospital, Kyoto

545-8586

Osaka City University Hospital, Osaka

554-0021

Goto Dermatology Clinic, Osaka

All Listed Sponsors
lead

Eli Lilly and Company

INDUSTRY

NCT04760314 - A Study of Lebrikizumab (LY3650150) in Combination With Topical Corticosteroids in Japanese Participants With Moderate-to-Severe Atopic Dermatitis | Biotech Hunter | Biotech Hunter